Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Types
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on End-users
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region
North America Oncology Informatics Market Revenue (US$ Million) By Country,
Europe Oncology Informatics Market Revenue (US$ Million) By Country,
Asia Pacific Oncology Informatics Market Revenue (US$ Million) By Country,
Latin America Oncology Informatics Market Revenue (US$ Million) By Country,
Middle East & Africa Oncology Informatics Market Revenue (US$ Million) By Country,
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oncology Informatics Market Snapshot
Chapter 4. Global Oncology Informatics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. COVID 19 Impact Analysis
4.7. Major Investment, Partnerships and Collaborations in Oncology Research
Chapter 5. Market Segmentation 1: By Types Estimates & Trend Analysis
5.1. By Types & Market Share, 2020 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Types:
5.2.1. Electronic Health Records (EHRs)
5.2.2. Population Health Management (PHM)
5.2.3. Clinical Decision Support System (CDSS)
5.2.4. Drug Discovery and Development Informatics
5.2.5. Image Analytics
Chapter 6. Market Segmentation 2: By End-Users Estimates & Trend Analysis
6.1. By End-Users & Market Share, 2020& 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:
6.2.1. Pharmaceutical Industry
6.2.2. Life Science Industry
6.2.3. Contract Research Organizations (CROs)
6.2.4. Academic Institutes and Research Centers
6.2.5. Others (Hospitals and Other Care Facilities)
Chapter 7. Oncology Informatics Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Oncology Informatics Market revenue (US$ Million) estimates and forecasts By Types, 2020-2030
7.1.2. North America Oncology Informatics Market revenue (US$ Million) estimates and forecasts By End-Users, 2020-2030
7.1.3. North America Oncology Informatics Market revenue (US$ Million) estimates and forecasts by country, 2020-2030
7.2. Europe
7.2.1. Europe Oncology Informatics Market revenue (US$ Million) By Types, 2020-2030
7.2.2. Europe Oncology Informatics Market revenue (US$ Million) By End-Users, 2020-2030
7.2.3. Europe Oncology Informatics Market revenue (US$ Million) by country, 2020-2030
7.3. Asia Pacific
7.3.1. Asia Pacific Oncology Informatics Market revenue (US$ Million) By Types, 2020-2030
7.3.2. Asia Pacific Oncology Informatics Market revenue (US$ Million) By End-Users, 2020-2030
7.3.3. Asia Pacific Oncology Informatics Market revenue (US$ Million) by country, 2020-2030
7.4. Latin America
7.4.1. Latin America Oncology Informatics Market revenue (US$ Million) By Types, (US$ Million)
7.4.2. Latin America Oncology Informatics Market revenue (US$ Million) By End-Users, (US$ Million)
7.4.3. Latin America Oncology Informatics Market revenue (US$ Million) by country, (US$ Million) 2020-2030
7.5. Middle East & Africa
7.5.1. Middle East & Africa Oncology Informatics Market revenue (US$ Million) By Types, (US$ Million)
7.5.2. Middle East & Africa Oncology Informatics Market revenue (US$ Million) By End-Users, (US$ Million)
7.5.3. Middle East & Africa Oncology Informatics Market revenue (US$ Million) by country, (US$ Million) 2020-2030
Chapter 8. Competitive Landscape
8.1. Company Profiles
8.1.1. Cerner Corporation
8.1.2. Change Healthcare
8.1.3. Elekta AB
8.1.4. F. Hoffmann-La Roche Ltd
8.1.5. Hologic, Inc.
8.1.6. IBM Corporation
8.1.7. Inspirata, Inc.
8.1.8. Koninklijke Philips N.V.
8.1.9. Laboratory Corporation of America Holdings
8.1.10. McKesson Corporation
8.1.11. MIM Software, Inc.
8.1.12. Oncology Analytics, Inc
8.1.13. PerkinElmer, Inc.
8.1.14. RELX Group
8.1.15. Sirenas, LLC
8.1.16. UnitedHealth Group, Inc
8.1.17. Varian Medical Systems, Inc
8.1.18. DOSIsoft SA
8.1.19. ViewRay Inc.
8.1.20. Prowess, Inc.
8.1.21. Flatiron Health
8.1.22. RaySearch Laboratories
8.1.23. Other Prominent Player
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.